Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Edit functionality is currently unavailable.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Pfeffer, Marc
Item TypeName
Academic Article Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programme.
Academic Article Food and Drug Administration: Cardiovascular and Renal Drugs Advisory Committee, 98th meeting, January 6th-7th, 2003.
Academic Article Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. SAVE Investigators.
Academic Article Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
Academic Article Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial.
Academic Article Myocardial infarct: no one size fits all.
Academic Article Pharmacologic advances in long-term heart failure management.
Academic Article Development of SHR hypertension and cardiac hypertrophy during prolonged beta blockade.
Academic Article Left ventricular remodeling and ventricular arrhythmias after myocardial infarction.
Academic Article AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute.
Academic Article [Effect of captopril on mortality and morbidity in patients with dysfunction of the left ventricle after myocardial infarction. Results on survival and hypertrophic studies].
Academic Article Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
Academic Article Beta-adrenergic blockers and survival in heart failure.
Academic Article Opposing effects of ß blockers and angiotensin-converting enzyme inhibitors on development of new-onset diabetes mellitus in patients with stable coronary artery disease.
Academic Article AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute.
Academic Article Effect of infarct artery patency on prognosis after acute myocardial infarction. The Survival and Ventricular Enlargement Investigators.
Academic Article Comparative effects of propranolol and nadolol on renal blood flow in normal rats and rats with congestive heart failure.
Academic Article The CHARM program: study design leads to findings of clinical and public health importance.
Concept Adrenergic beta-Antagonists
Academic Article Searching for treatments of heart failure with preserved ejection fraction: matching the data to the question.
Academic Article Estimating Treatment Effect With Clinical Interpretation From a Comparative Clinical Trial With an End Point Subject to Competing Risks.
Academic Article Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial.
Search Criteria
  • Adrenergic beta Antagonists
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.